Uniphar plc (AIM:UPR)
London · Delayed Price · Currency is GBP · Price in GBX 345.00
0.00 (0.00%)
At close: Feb 13, 2026
Uniphar Market Cap
Uniphar has a market cap or net worth of 895.09 million as of February 13, 2026. Its market cap has increased by 67.50% in one year.
Market Cap
895.09M
Enterprise Value
1.20B
Revenue
2.48B
Ranking
n/a
PE Ratio
15.75
Stock Price
345.00
Market Cap Chart
Since July 17, 2019, Uniphar's market cap has increased from 284.47M to 895.09M, an increase of 214.66%. That is a compound annual growth rate of 19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 895.09M | 12.29% |
| Dec 31, 2025 | 797.09M | 66.53% |
| Dec 31, 2024 | 478.64M | -25.17% |
| Dec 29, 2023 | 639.68M | -14.79% |
| Dec 30, 2022 | 750.70M | -34.52% |
| Dec 31, 2021 | 1.15B | 96.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Oxford Nanopore Technologies | 1.31B |
| Oxford Biomedica | 986.00M |
| CVS Group | 975.17M |
| Spire Healthcare Group | 800.72M |